bpc-157 tumor growth study and the Difference Between an Evidence Gap and a Cover-Up: What the entire human evidence base actually looks like, and the questions to ask next. — WellFounded BPC-157 is being marketed as
Description
Its status as a research-only chemical automatically places it on the prohibited list
Ready to experience the difference for yourself

I think we can safely say the overwhelming answer would be (b)

Provider education programs, staff training, and system modifications all require time and financial resources that compete with other healthcare priorities
